Nasdaq to delist ZyVersa Therapeutics common stock effective ~Sep 28, 2025

ZyVersa Therapeutics, Inc.

Nasdaq notified ZyVersa on Sept 14, 2025, of delisting; Form 25 to be filed on or about Sept 18, 2025.
Stock was suspended from Nasdaq on July 17, 2025; trading on OTCQB since July 28, 2025 under symbol ZVSA.
Delisting effective ten days after Form 25 filing; company cites failure to meet minimum bid price rule.
Company's common stock will continue trading on OTCQB without disruption.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.